Miles Linde (@mileslinde) profile picture

Postdoctoral fellow @fredhutch co-advised by @GhajarLab and Dr. Stanley Riddell. Studying how the immune system regulates breast cancer dormancy and metastasis.

Joined February 2020
Photo by Miles Linde (@mileslinde)Photo by Miles Linde (@mileslinde)Photo by Miles Linde (@mileslinde)
I am so excited to finally see my PhD work out in @CD_AACR. We were able to investigate the immunotherapeutic benefit of reprogramming cancer cells into antigen presenting cells and were surprised by the dramatic responses we observed. A brief thread on our findings:
Now online in @CD_AACR: Reprogramming Cancer into Antigen Presenting Cells as a Novel #Immunotherapy - by @mileslinde @majetilab and colleagues @StanfordMed aacrjournals.org/cancerdisco…
5
21
2
98
24,001
Miles Linde retweeted
c-Jun overexpression fails to prevent CAR T cell exhaustion in tumors, but PD-L1 blockade restores c-Jun levels and CAR T cell activity @SciImmunology science.org/doi/10.1126/scii… @fredhutch
15
1
64
3,689
Now online in @CD_AACR: DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency - by @ThomasKoehnke, @DKarigane @majetilab and colleagues doi.org/10.1158/2159-8290.CD… @StanfordMed
12
55
6,564
What a blast to see @RaviMajetiMD at @fredhutch giving the TST seminar this afternoon. Exciting recent work from close @majetilab friends @ThomasKoehnke, @amycfanphd, and Daiki on clonal competition in AML and DNMT3A’s role in leukemia initiation. Proud to be a Majeti lab alum!
2
1
28
1,513
Miles Linde retweeted
Our work on ASXL1 mutations in clonal hematopoiesis and myeloid malignancies - @ThomasKoehnke @BCD_AACR #BloodCancer #Cancer #Leukemia #MyeloidMalignancies #OncoDaily #Oncology #TothovaLab oncodaily.com/36016.html
5
15
888
Read this week's Cancer Discovery #ResearchWatch: Relative Scarcity of Disseminated Tumor Cells Enables Immune Evasion, summarizing the work of Erica T. Goddard, @mileslinde, Stanley R. Riddell, @GhajarLab et al. bit.ly/42pyPn6 @fredhutch
1
7
1,956
Miles Linde retweeted
While dormant disseminated tumor cells (DTCs) downregulate MHC-I, the primarily evade antitumor immunity though “relative scarcity”. More details here 👉 bit.ly/3HoAGim  @fredhutch  @GhajarLab
2
2
9
1,651
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies dlvr.it/T1Clmm
1
26
3
76
13,306
Miles Linde retweeted
Our @GhajarLab and Riddell Lab team up for a study that explains why dormant tumor cells evade immune surveillance, and how this can be overcome towards curative therapy. This is what #METX aims to achieve more of.
Our latest - in joint collaboration w/ Stan Riddell’s Lab here at the Hutch – reveals a novel mode of immune evasion we call “relative scarcity” that explains why dormant disseminated tumor cells escape surveillance by antigen-directed T cells: authors.elsevier.com/a/1iOZY… (1/n)
2
8
858
Miles Linde retweeted
Our latest - in joint collaboration w/ Stan Riddell’s Lab here at the Hutch – reveals a novel mode of immune evasion we call “relative scarcity” that explains why dormant disseminated tumor cells escape surveillance by antigen-directed T cells: authors.elsevier.com/a/1iOZY… (1/n)
24
36
6
116
19,287
Disseminated tumor cells (DTCs) -the root of metastatic relapse- evade T cell immunosurveillance at least in part through infrequent interactions with antigen specific T cells. This paucity of interactions can be overcome with T cell immunotherapy. authors.elsevier.com/c/1iOZY…
1
4
15
1,500
Finally, go check out @GhajarLab’s thread for a thorough discussion on our findings (and even more thank yous to collaborators and funding)!
1
2
112
IDH1-mutant preleukemic #hematopoietic #stemcells can be eliminated by inhibition of oxidative phosphorylation, by Niklas Landberg, @majetilab et al. bit.ly/48dWQzA @StanfordMed #LeuSM
2
15
1,113
In the May issue— Reprogramming Cancer into Antigen Presenting Cells as a Novel #Immunotherapy, by @mileslinde, @majetilab et al. https://teapaw.org/t.co/4s4W2lpM2W @StanfordMed
4
13
2,970
Thank you to @ACIR_org for highlighting our work! A clear and concise, yet thoughtful and comprehensive description of our studies complemented by a phenomenal graphical depictions!
Reprogramming tumors to present themselves to the immune system. Read our digest here 👉 https://teapaw.org/t.co/rD1RZ3GDre @stanfordMed @majetilab @mileslinde
1
3
12
1,644
A particular thank you to @Wouterville for the writing and Lauren Hitchings for the graphical abstract!
2
120